Cargando…

Thymopoiesis in Pre- and Post-Hematopoietic Stem Cell Transplantation

Hematopoietic stem cell transplantation (HSCT) is an important therapeutic option for some hematological diseases. However, patients who undergo HSCT acquire a state of immunodeficiency that causes significant mortality. Reconstitution of thymic function is needed to support the immune system. One w...

Descripción completa

Detalles Bibliográficos
Autores principales: da Rocha, Luis Klaus A., Freschi de Barros, Samar, Bandeira, Francine, Bollini, Alexia, Testa, Lucia Helena de A., Simione, Anderson João, Souza, Marina de O. e, Zanetti, Lilian P., de Oliveira, Leila Cibele S., dos Santos, Ana Claúdia F., de Souza, Mair Pedro, Colturado, Vergílio Antônio R., Kalil, Jorge, Machado, Clarisse M., Guilherme, Luiza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137257/
https://www.ncbi.nlm.nih.gov/pubmed/30245685
http://dx.doi.org/10.3389/fimmu.2018.01889
_version_ 1783355152073228288
author da Rocha, Luis Klaus A.
Freschi de Barros, Samar
Bandeira, Francine
Bollini, Alexia
Testa, Lucia Helena de A.
Simione, Anderson João
Souza, Marina de O. e
Zanetti, Lilian P.
de Oliveira, Leila Cibele S.
dos Santos, Ana Claúdia F.
de Souza, Mair Pedro
Colturado, Vergílio Antônio R.
Kalil, Jorge
Machado, Clarisse M.
Guilherme, Luiza
author_facet da Rocha, Luis Klaus A.
Freschi de Barros, Samar
Bandeira, Francine
Bollini, Alexia
Testa, Lucia Helena de A.
Simione, Anderson João
Souza, Marina de O. e
Zanetti, Lilian P.
de Oliveira, Leila Cibele S.
dos Santos, Ana Claúdia F.
de Souza, Mair Pedro
Colturado, Vergílio Antônio R.
Kalil, Jorge
Machado, Clarisse M.
Guilherme, Luiza
author_sort da Rocha, Luis Klaus A.
collection PubMed
description Hematopoietic stem cell transplantation (HSCT) is an important therapeutic option for some hematological diseases. However, patients who undergo HSCT acquire a state of immunodeficiency that causes significant mortality. Reconstitution of thymic function is needed to support the immune system. One way to measure thymic function is through T-cell receptor excision circle (TREC) quantification. TRECs are generated by T-cell receptor gene rearrangements during T-cell maturation in the thymus and represent a reliable marker for thymic output. In this study, we aimed to assess aging and malignant hematological diseases as two important factors that may influence thymic output before HSCT. We observed that patients before HSCT presented signal joint TREC (sjTREC) numbers lower than 606.55 copies/μg DNA (low values) compared with healthy individuals, with an odds ratio (OR) of 12.88 [95% confidence interval (CI): 5.26–31.53; p < 0.001]. Our results showed that a group of older individuals (≥50 years old), comprising both healthy individuals and patients, had an OR of 10.07 (95% CI: 2.80–36.20) for low sjTREC values compared with younger individuals (≤24 years old; p < 0.001). Multiple logistic regression analysis confirmed that both older age (≥50 years old) and malignant hematological diseases and their treatments were important and independent risk factors related to thymic function impairment (p < 0.001). The median sjTREC value for patients of all ages was significantly lower than the sjTREC median for the subgroup of older healthy individuals (≥50 years old; p < 0.001). These data suggested that patients before HSCT and healthy individuals exhibited age-dependent thymic impairment, and that prior treatment for hematological diseases may exacerbate aging-related deterioration of natural thymic function. Furthermore, we analyzed these patients 9 months post-HSCT and compared patients who underwent autologous HSCT with those who underwent allogeneic HSCT. Both groups of patients achieved sjTREC copy numbers similar to those of healthy individuals. We did not find a close relationship between impaired thymic function prior to HSCT and worse thymic recovery after HSCT.
format Online
Article
Text
id pubmed-6137257
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-61372572018-09-21 Thymopoiesis in Pre- and Post-Hematopoietic Stem Cell Transplantation da Rocha, Luis Klaus A. Freschi de Barros, Samar Bandeira, Francine Bollini, Alexia Testa, Lucia Helena de A. Simione, Anderson João Souza, Marina de O. e Zanetti, Lilian P. de Oliveira, Leila Cibele S. dos Santos, Ana Claúdia F. de Souza, Mair Pedro Colturado, Vergílio Antônio R. Kalil, Jorge Machado, Clarisse M. Guilherme, Luiza Front Immunol Immunology Hematopoietic stem cell transplantation (HSCT) is an important therapeutic option for some hematological diseases. However, patients who undergo HSCT acquire a state of immunodeficiency that causes significant mortality. Reconstitution of thymic function is needed to support the immune system. One way to measure thymic function is through T-cell receptor excision circle (TREC) quantification. TRECs are generated by T-cell receptor gene rearrangements during T-cell maturation in the thymus and represent a reliable marker for thymic output. In this study, we aimed to assess aging and malignant hematological diseases as two important factors that may influence thymic output before HSCT. We observed that patients before HSCT presented signal joint TREC (sjTREC) numbers lower than 606.55 copies/μg DNA (low values) compared with healthy individuals, with an odds ratio (OR) of 12.88 [95% confidence interval (CI): 5.26–31.53; p < 0.001]. Our results showed that a group of older individuals (≥50 years old), comprising both healthy individuals and patients, had an OR of 10.07 (95% CI: 2.80–36.20) for low sjTREC values compared with younger individuals (≤24 years old; p < 0.001). Multiple logistic regression analysis confirmed that both older age (≥50 years old) and malignant hematological diseases and their treatments were important and independent risk factors related to thymic function impairment (p < 0.001). The median sjTREC value for patients of all ages was significantly lower than the sjTREC median for the subgroup of older healthy individuals (≥50 years old; p < 0.001). These data suggested that patients before HSCT and healthy individuals exhibited age-dependent thymic impairment, and that prior treatment for hematological diseases may exacerbate aging-related deterioration of natural thymic function. Furthermore, we analyzed these patients 9 months post-HSCT and compared patients who underwent autologous HSCT with those who underwent allogeneic HSCT. Both groups of patients achieved sjTREC copy numbers similar to those of healthy individuals. We did not find a close relationship between impaired thymic function prior to HSCT and worse thymic recovery after HSCT. Frontiers Media S.A. 2018-09-07 /pmc/articles/PMC6137257/ /pubmed/30245685 http://dx.doi.org/10.3389/fimmu.2018.01889 Text en Copyright © 2018 Rocha, Freschi de Barros, Bandeira, Bollini, Testa, Simione, Souza, Zanetti, Oliveira, Santos, Souza, Colturado, Kalil, Machado and Guilherme. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
da Rocha, Luis Klaus A.
Freschi de Barros, Samar
Bandeira, Francine
Bollini, Alexia
Testa, Lucia Helena de A.
Simione, Anderson João
Souza, Marina de O. e
Zanetti, Lilian P.
de Oliveira, Leila Cibele S.
dos Santos, Ana Claúdia F.
de Souza, Mair Pedro
Colturado, Vergílio Antônio R.
Kalil, Jorge
Machado, Clarisse M.
Guilherme, Luiza
Thymopoiesis in Pre- and Post-Hematopoietic Stem Cell Transplantation
title Thymopoiesis in Pre- and Post-Hematopoietic Stem Cell Transplantation
title_full Thymopoiesis in Pre- and Post-Hematopoietic Stem Cell Transplantation
title_fullStr Thymopoiesis in Pre- and Post-Hematopoietic Stem Cell Transplantation
title_full_unstemmed Thymopoiesis in Pre- and Post-Hematopoietic Stem Cell Transplantation
title_short Thymopoiesis in Pre- and Post-Hematopoietic Stem Cell Transplantation
title_sort thymopoiesis in pre- and post-hematopoietic stem cell transplantation
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137257/
https://www.ncbi.nlm.nih.gov/pubmed/30245685
http://dx.doi.org/10.3389/fimmu.2018.01889
work_keys_str_mv AT darochaluisklausa thymopoiesisinpreandposthematopoieticstemcelltransplantation
AT freschidebarrossamar thymopoiesisinpreandposthematopoieticstemcelltransplantation
AT bandeirafrancine thymopoiesisinpreandposthematopoieticstemcelltransplantation
AT bollinialexia thymopoiesisinpreandposthematopoieticstemcelltransplantation
AT testaluciahelenadea thymopoiesisinpreandposthematopoieticstemcelltransplantation
AT simioneandersonjoao thymopoiesisinpreandposthematopoieticstemcelltransplantation
AT souzamarinadeoe thymopoiesisinpreandposthematopoieticstemcelltransplantation
AT zanettililianp thymopoiesisinpreandposthematopoieticstemcelltransplantation
AT deoliveiraleilacibeles thymopoiesisinpreandposthematopoieticstemcelltransplantation
AT dossantosanaclaudiaf thymopoiesisinpreandposthematopoieticstemcelltransplantation
AT desouzamairpedro thymopoiesisinpreandposthematopoieticstemcelltransplantation
AT colturadovergilioantonior thymopoiesisinpreandposthematopoieticstemcelltransplantation
AT kaliljorge thymopoiesisinpreandposthematopoieticstemcelltransplantation
AT machadoclarissem thymopoiesisinpreandposthematopoieticstemcelltransplantation
AT guilhermeluiza thymopoiesisinpreandposthematopoieticstemcelltransplantation